首页> 外文期刊>Minimally invasive therapy and allied technologies: MITAT : official journal of the Society for Minimally Invasive Therapy >Clinical use of a neuronavigation system in hemangioblastoma resection of posterior cranial fossa
【24h】

Clinical use of a neuronavigation system in hemangioblastoma resection of posterior cranial fossa

机译:神经导航系统在颅后颅窝血管母细胞瘤切除术中的临床应用

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to retrospectively evaluate the effectiveness of the Stryker Leibinger neuronavigation system in surgical resection of hemangioblastomas of the posterior fossa. The study included 16 cases of solid hemangioblastoma of posterior cranial fossa treated since we began using Stryker Leibinger neuronavigation system-assisted microneurosurgery in 2003. These cases were compared on the basis of time, blood loss, and complications to 19 similar cases of solid hemangioblastoma that underwent conventional microneurosurgical resection prior to 2003. All patients in the experimental (neuronavigation-assisted) group underwent surgical resection without complications while the control groups' resections all involved blood loss related to the longer operation time. Neuronavigation also resulted in a clear field of surgical vision and clear lesion boundaries, making it easier to remove lesions and reduce accidental injury of adjacent normal structures. The application of navigation technology is very valuable for solid hemangioblastoma operations not only by shortening operative time, thereby significantly reducing operative blood loss, but also by making surgical excision easier, reducing damage to adjacent normal structures, and decreasing surgical complications and mortality.
机译:这项研究的目的是回顾性评估Stryker Leibinger神经导航系统在后颅窝血管母细胞瘤手术切除中的有效性。自2003年我们开始使用Stryker Leibinger神经导航系统辅助微神经外科手术以来,该研究包括16例颅后颅窝实体血管母细胞瘤的治疗。根据时间,失血量和并发症,将这些病例与19例相似的实体血管母细胞瘤进行了比较。在2003年之前进行了常规的显微神经外科手术切除术。实验组(神经营养辅助)组的所有患者均进行了手术切除而无​​并发症,而对照组的切除术均涉及失血,这与手术时间较长有关。神经导航还可以带来清晰的手术视野和清晰的病灶边界,从而更易于清除病灶并减少相邻正常结构的意外伤害。导航技术的应用不仅可以缩短手术时间,从而显着减少手术失血量,而且可以简化手术切除,减少对邻近正常结构的损伤,降低手术并发症和死亡率,因此对于实体血管母细胞瘤手术非常有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号